Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC

Conditions: Extensive-stage Small-cell Lung Cancer Interventions: Radiation: Thoracic Radiochemotherapy; Drug: durvalumab; Radiation: Stereotactic radiotherapy of further tumor locations; Drug: Chemotherapy Sponsors: Universit ät des Saarlandes Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials